The advanced therapy industry is constrained by its focus on manufacturing. The drive to reduce COGS, close and automate processes, create assay platforms, etc. are all critical.
However as advanced therapies increasingly reach market authorisation they need to utilise a logistics platform that connects patients to therapies.
Article by Dr Matthew Lakelin - 30 Jan 2018
Dr Matthew Lakelin is a co-founder of TrakCel. Using his knowledge in handling and distribution of CGTs he has assisted with the development of the technology platform, writing user-stories for GMP critical functions. Matthew provides a technical bridge between the software development side of the technology platform and the GxP application of the system to ensure that the platform constantly evolves to meet customer needs as therapies change and develop.